PeptideExaminer alleges that the FDA raided Amino Asylum's warehouse in June 2025 and reports a shutdown, but no identified agency record independently confirms the raid here. The guilty pleas often attached to this story were entered by people at Paradigm Peptides, a different business.
Buy 1, Get 1 20% Off
Pick any two research compounds. Take 20% off the lower priced one.
Applied automatically at checkout, no code needed
Claim my 20% off →In every pair, the lower priced item is 20% off after other discounts; accessories excluded. For research use only.
What does the June 2025 account say?
The vendor profile also describes an offline storefront and customer reports of stalled orders. It repeats claims about warning letters and product contents without linking an Amino Asylum-specific government document. Its FDA allegation does not establish the legal basis or outcome of the reported action.
Why do the Paradigm guilty pleas keep appearing in this story?
The December 2025 pleas belonged to Matthew Kawa and Jennifer Stechkober in the Paradigm Peptides case. The Justice Department identified Paradigm R.E. LLC as Kawa's business and described products advertised as SARMs that investigators found contained testosterone. It did not identify Amino Asylum as that defendant. (DOJ)
The Paradigm DOJ case page also describes a victim-witness process specific to purchases in that case. It names no Amino Asylum defendant.
What would establish an Amino Asylum agency action?
A warning letter names its recipient, reviewed site and alleged violations. For contrast, FDA's March 2026 letter to Gram Peptides identifies Gram and describes website claims despite research-only wording; it says nothing about Amino Asylum. A warrant, agency statement or case filing naming Amino Asylum would be needed to pin down the reported warehouse action's authority and outcome.
What remains unconfirmed about Amino Asylum?
The vendor account does not establish a reopening or identify who now operates any similarly branded storefront.
An Amino Asylum alternative is not part of the reported agency action simply because it offers research materials. Our separate research-supplier guide addresses documentation; IQON Labs advertises here and is not certified as a replacement by this reporting.
The account remains an industry report, not a documented federal case against Amino Asylum.
Frequently Asked Questions
What happened to Amino Asylum?
PeptideExaminer reports a June 2025 warehouse raid and shutdown. We have not identified a public FDA or DOJ record naming Amino Asylum that confirms the details.
Why was Amino Asylum raided?
The reason is not established by an identified primary record in this article. Findings from the Paradigm Peptides prosecution should not be assigned to Amino Asylum.
Did Amino Asylum's founders plead guilty in December 2025?
The DOJ record cited here concerns Matthew Kawa and Jennifer Stechkober of Paradigm Peptides. It does not support that claim about Amino Asylum.
Is Amino Asylum coming back?
We do not have an attributable reopening announcement. A site using similar branding does not by itself establish that the former operator has returned.
Is an Amino Asylum alternative connected to the reported action?
The cited account does not establish that another seller succeeded Amino Asylum or was involved in the reported action. IQON Labs appears in commercial placements on this page, not as an independently certified replacement.
Related Coverage
An agency record naming Amino Asylum and the premises would establish who conducted the reported search. Until then, the FDA allegation remains unconfirmed and separate from the documented Paradigm prosecution.
Buy 1, Get 1 20% Off
Pick any two research compounds. Take 20% off the lower priced one.
Applied automatically at checkout, no code needed
Claim my 20% off →In every pair, the lower priced item is 20% off after other discounts; accessories excluded. For research use only.
Updated September 26, 2026. Sources are linked in the text. For information only, not medical or legal advice. IQON Labs appears in commercial placements on this page. Research products are not for human consumption.